Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.800 | None | 0.983 | 1724 | 14 | 1982 | 2020 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.700 | None | 0.969 | 760 | 4 | 1980 | 2020 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.500 | None | 0.976 | 41 | 2 | 1997 | 2019 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.450 | None | 0.800 | 5 | 0 | 2010 | 2019 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
disease | 0.440 | None | 1.000 | 4 | 0 | 1997 | 2016 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.440 | None | 1.000 | 4 | 0 | 1990 | 2014 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.430 | None | 1.000 | 3 | 0 | 2011 | 2015 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.400 | None | 1.000 | 26 | 0 | 1993 | 2019 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 1986 | 2020 | |||||||||
|
proteinase 3 | 0.503 | 0.808 | 3.8E-05 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 1997 | 2011 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 1994 | 2018 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.380 | None | 1.000 | 8 | 0 | 2000 | 2013 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.360 | None | 1.000 | 6 | 1 | 2010 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.360 | None | 1.000 | 6 | 1 | 2004 | 2016 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2006 | 2017 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.350 | None | 0.833 | 5 | 0 | 2009 | 2017 | ||||||||
|
hyaluronan mediated motility receptor | 0.544 | 0.615 | 5.5E-21 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2002 | 2006 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2018 | ||||||||
|
cryptochrome circadian regulator 2 | 0.599 | 0.692 | 3.2E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2011 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
period circadian regulator 3 | 0.559 | 0.731 | 1.4E-17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
hes family bHLH transcription factor 1 | 0.468 | 0.885 | 0.71 |
|
disease | 0.230 | None | 1.000 | 3 | 0 | 2010 | 2015 | ||||||||
|
signal-induced proliferation-associated 1 | 0.638 | 0.538 | 4.6E-03 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.210 | None | 1.000 | 1 | 4 | 2010 | 2016 |